Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sobi
Pharma
Apellis scraps pegcetacoplan development in ALS after trial flop
The study missed both primary and secondary endpoints after a prior "clinical setback" in the open-label extension arm.
Zoey Becker
May 25, 2023 10:37am
In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo
May 10, 2023 11:25am
RSV antibody deal revamped among AZ, Sanofi and Sobi
Apr 10, 2023 11:29am
'The Top Line': Fierce Medtech's annual Fierce 15 honorees
Mar 24, 2023 6:00am
'The Top Line': Surprising multibillion-dollar medtech M&A deals
Mar 3, 2023 6:00am
Sanofi's Altuviiio gets a new factor in drug naming
Feb 27, 2023 9:00am